Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer

BACKGROUND: Molecular subtyping of cancer aimed to predict patient overall survival (OS) and nominate drug targets for patient treatments is central to precision oncology. Owing to the rapid development of phosphoproteomics, we can now measure thousands of phosphoproteins in human cancer tissues. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Mengsha, Yu, Chunyu, Zhan, Dongdong, Zhang, Ming, Zhen, Bei, Zhu, Weimin, Wang, Yi, Wu, Congying, He, Fuchu, Qin, Jun, Li, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412074/
https://www.ncbi.nlm.nih.gov/pubmed/30594550
http://dx.doi.org/10.1016/j.ebiom.2018.12.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412074/
https://www.ncbi.nlm.nih.gov/pubmed/30594550
http://dx.doi.org/10.1016/j.ebiom.2018.12.039

Ejemplares similares